Inventor
Lennart Hansson
Inventor
Umea, SE
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes17%
C07KPeptides15%
A61KPreparations for medical, dental or toiletry purposes12%
A01KAnimal husbandry7%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations7%
A23CDairy products, e.g. milk, butter or cheese5%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
A61QSpecific use of cosmetics or similar toiletry preparations3%
B29CShaping or joining of plastics3%
B29LIndexing scheme associated with subclass b29c, relating to particular articles3%
PatentTitleYear
8,003,077'Method for the production of hyperpolarized 129Xe'20117,372,274'Methods and devices configured for dissolving hyperpolarised solid material with a solvent within a cryostat for NMR analyses'20087,019,194'SCCE modified transgenic mammals and their use as models of human disease'20066,682,733'Fibrinolytic enzymes'20046,232,094'DNA encoding human .kappa. casein and process for obtaining the protein'20016,222,094'Transgenic non-human mammal expressing the DNA sequence encoding kappa casein mammary gland and milk'20016,143,872'Borrelia burdorferi Osp A and B proteins and immunogenic peptides'20006,112,498'Packaging unit for continuously producing sealed packages, containing pourable food products, from a tube of packaging material'20006,035,615'Packaging unit for continuously producing sealed packages, containing pourable food products, from a tube of packaging material'20006,025,540'Transgenic non-human mammals producing EC-SOD protein in their milk'20005,981,256'Recombinant stratum corneum chymotryptic enzyme (SCCE)'19995,942,254'Phosphorylated recombinant human .beta.-casein expressed in a bacterial system'19995,834,290'Recombinant stratum corneum chymotryptic enzyme (SCCE)'19985,807,702'Method for expressing phosphorylated recombinant human .beta.-casein in a bacterial system'19985,777,095'Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90'19985,710,044'Plasmid for expressing phosphorylated recombinant proteins in a bacterial system'19984,921,310'Tool for breaking, cutting or working of solid materials'19904,406,792'Separation agent'1983Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1990–2006Patents assigned to HANSSON LENNART (2)· patent assignee history
1998–2001Patents assigned to SYMBICOM AB (4)· patent assignee history
1998–1999Patents assigned to ABBOTT LAB (3)· patent assignee history
1998–1999Patents assigned to ASTRA AB (2)· patent assignee history
1998–2001Based in Umea, SE· patent location history
1999–2001Based in Sp.ang.nga, SE· patent location history
2000Based in Bjarred, SE· patent location history
2006Based in Pixbo, SE· patent location history
2008–2011Patents assigned to GE HEALTHCARE AS (2)· patent assignee history
2008–2011Based in Malmo, SE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SYMBICOM AB | 4 | 1998–2001 |
| ABBOTT LAB | 3 | 1998–1999 |
| ASTRA AB | 2 | 1998–1999 |
| GE HEALTHCARE AS | 2 | 2008–2011 |
| HANSSON LENNARTself | 2 | 1990–2006 |
Locations
| Location | Patents | Span |
|---|---|---|
| Umea, SE | 6 | 1998–2001 |
| Sp.ang.nga, SE | 3 | 1999–2001 |
| Malmo, SE | 2 | 2008–2011 |
| Bjarred, SE | 2 | 2000 |
| Pixbo, SE | 1 | 2006 |